Switch to:
Biomarin Pharmaceutical Inc (NAS:BMRN)
EV/EBITDA
-296.50 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Biomarin Pharmaceutical Inc's enterprise value is $22,467.0 Mil. Biomarin Pharmaceutical Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2015 was $-75.8 Mil. Therefore, Biomarin Pharmaceutical Inc's EV/EBITDA ratio for today is -296.50.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Biomarin Pharmaceutical Inc's stock price is $144.56. Biomarin Pharmaceutical Inc's earnings per share for the trailing twelve months (TTM) ended in Mar. 2015 was $-1.08. Therefore, Biomarin Pharmaceutical Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Biomarin Pharmaceutical Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=22467.001/-75.774
=-296.50

Biomarin Pharmaceutical Inc's current Enterprise Value is $22,467.0 Mil.
Biomarin Pharmaceutical Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2015 was -4.81 (Jun. 2014 ) + 26.559 (Sep. 2014 ) + -39.717 (Dec. 2014 ) + -57.806 (Mar. 2015 ) = $-75.8 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Biomarin Pharmaceutical Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=144.56/-1.081
=

Biomarin Pharmaceutical Inc's share price for today is $144.56.
Biomarin Pharmaceutical Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2015 was -0.23 (Jun. 2014 ) + 0.05 (Sep. 2014 ) + -0.471 (Dec. 2014 ) + -0.43 (Mar. 2015 ) = $-1.08.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Biomarin Pharmaceutical Inc Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
ev2ebitda -17.86-101.46-325.1726.4558.82180.644,674.71-94.71-83.82-341.51

Biomarin Pharmaceutical Inc Quarterly Data

Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15
ev2ebitda -94.71-95.76-104.69-88.93-83.82-90.32-84.92-262.34-341.51-259.36
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK